AI-Integrated Real-Time Quality Control Analysis Service

Online Inquiry

Background Service What We Can Offer Workflow Highlights FAQs Contact

Creative Biolabs provides an AI-Integrated Real-Time Quality Control Analytics Service to address key challenges in cell therapy bioproduction, including batch-to-batch variability, donor-specific inconsistencies, and the risks associated with reactive endpoint testing. This service enables proactive quality control by identifying critical quality attributes (CQAs) early in the manufacturing process through advanced multi-omics integration and symbolic regression modeling. By detecting key indicators such as memory phenotypes and metabolic fitness within the first 96 hours of expansion, Creative Biolabs ensures consistent product quality, maximized therapeutic potency, and improved clinical efficacy well before infusion.

Introduction

Recent advances in data-driven bioprocess monitoring show that combining multi-source data, including cell morphology, metabolite profiles, and process parameters, supports early prediction of final cell quality and potency. Research indicates that predictive models can reliably link early-stage culture signals with end-product functionality. Image-based analytics and virtual sensors also enable non-invasive, real-time quality evaluation. These methods move quality control from reactive testing to proactive management, greatly improving consistency and scalability in cell therapy production.

Multi-omics integration combined with process parameter optimization to support predictive modeling. (OA Literature) Fig.1 Process parameter optimization and multi-omics integration for predictive modeling. ¹

Service

Our service transforms your manufacturing data from a historical record into a predictive tool. We assist your project by delivering high-resolution insights into the biological "state" of your culture, allowing for real-time adjustments that prevent batch failure and maximize the yield of potent, long-lasting therapeutic cells. By bridging the gap between raw data and actionable intelligence, we help you secure regulatory approval and clinical success.

Our platform enables real-time potency prediction by continuously estimating cell functionality through in-process data instead of relying only on endpoint assays. It supports dynamic monitoring of critical quality attributes, including viability, phenotype, metabolic activity, and functional markers, while ensuring batch consistency via early deviation detection and reduced failure risks. Additionally, it delivers actionable insights for process optimization and provides anomaly detection with early warnings for subtle process drifts. With these features, clients benefit from shortened development timelines, enhanced manufacturing reproducibility, and data-backed regulatory readiness.

Discover How We Can Help - Request a Consultation.

What We Can Offer

Multi-Modal Data Integration	AI & Machine Learning Modeling
Process parameters (pH, dissolved oxygen, temperature). Metabolite and nutrient profiling (e.g., glucose, lactate). Cell morphology imaging and growth kinetics.	Time-series predictive modeling for potency estimation Deep learning-based image analysis for cell state classification Multivariate analysis for CQA identification and correlation
Soft Sensor Development	Real-Time Monitoring & Control
Virtual sensing models to infer hard-to-measure attributes such as potency. Continuous estimation of functional markers during culture.	Integration with process analytical technologies. Automated anomaly detection and alert systems. Feedback-enabled process adjustment strategies.

Our Workflow

Required Starting Materials: To initiate the service, clients typically provide 2-3 specific biological inputs, such as cryopreserved peripheral blood mononuclear cells or mesenchymal stem cells from 3-5 distinct donors, along with detailed media formulations and expansion protocols currently in use.

Workflow of AI-Integrated Real-Time Quality Control Analytics Service. (Creative Biolabs Original)

Final Deliverables: Clients receive a Comprehensive Potency Forecast Report detailing predicted CD4/CD8 ratios and memory cell percentages, a Validated Mathematical Model for proprietary use, and a Real-Time Bioprocess Dashboard for ongoing monitoring.

Core Benefits

Real-time machine vision for label-free monitoring of cell morphology and differentiation drift.
Customized predictive algorithms tailored for specific therapeutic cell types.
Automated anomaly detection systems to identify contamination or metabolic shifts in real-time.
High-standard quality control tools to quantify and evaluate the long-term persistence potential of the final product.
Cloud-based or on-site data integration platforms with end-to-end encryption for maximum data security.

FAQs

Q: How early can your system predict the final potency of a cell batch?

A: Our models are trained to identify predictive signatures as early as Day 4 or Day 6 of the expansion process, providing a 10-day lead time over traditional endpoint testing.

Q: Does your AI require massive amounts of historical data to work?

A: No. By using Symbolic Regression rather than deep learning, we can build highly accurate, biologically relevant models using smaller, high-quality data sets from your specific process.

Q: Is this service compatible with closed-system bioreactors?

A: We specialize in non-invasive sampling techniques and integration with existing sensor arrays commonly found in automated closed systems.

Q: How do you ensure the security of our proprietary manufacturing data?

A: Data integrity is paramount. We offer end-to-end encrypted cloud solutions or localized on-site deployment, ensuring your proprietary bioprocess data never leaves your control.

Partner with Us

Creative Biolabs provides a world-class AI-integrated real-time quality control analytics service that empowers biopharmaceutical companies to manage the complexity of living therapies. By shifting from reactive testing to predictive monitoring, this solution leverages multi-source data and advanced analytical models to enable continuous monitoring and early prediction of critical quality attributes in cell manufacturing, forecast final cell potency, dynamically optimize production processes, and help ensure consistent, successful batch outcomes. For detailed information or to discuss tailoring our AI platform to your specific cell therapy pipeline, please contact our team.

Reference

Odeh-Couvertier, Valerie Y et al. "Predicting T-cell quality during manufacturing through an artificial intelligence-based integrative multiomics analytical platform." Bioengineering & translational medicine vol. 7,2 e10282. 4 Jan. 2022. Distributed under Open Access License CC BY 4.0, without modification. https://doi.org/10.1002/btm2.10282

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.